New Scientist Magazine described a genetically engineered “magic bullet” that may effectively many common cancers. Initial tests reveal that the “magic bullets” effectively treated adenocarcinomas, which are found in cancers of the lung, ovary, breast, colon, and prostate. The bullets injecting tumors with a deadly bacterial toxin, killing the cancerous cells without harming the healthy surrounding tissue.
The “magic bullet” was developed by Jerusalem-based Medical Targeting Recognition Technologies. Clinical trials with colon cancer patients may commence by early 1999.
